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Birth weight and risk of renal cell cancer. cell cancer [5–8]. Moreover, low birth weight has been
Background. The prenatal period has been suggested to be related to an increased prevalence of overt albuminuria,
important for future cancer risk. Conditions in utero are also a marker of renal disease [9]. Birth weight is linearlyimportant for the development of the kidney, and birth weight,
correlated to the number of nephrons, the structurala marker of fetal nutrition and growth, is linearly correlated
and functional unit of the kidney [10]. An associationwith the number of nephrons and the structural and functional
unit of the kidney. An association between birth weight and between birth weight and renal cell cancer, the major
renal cell cancer, the major form of kidney cancer, is biologi- form of kidney cancer, is therefore biologically plausible,
cally plausible, but has never been studied.
but to our knowledge, this relationship has never beenMethods. We conducted a population-based, case-controlled
studied.study in Sweden of men and women aged 20 to 79 years.
We collected self-reported information on categories of birth We evaluated the association between birth weight
weight from 648 patients with newly diagnosed renal cell cancer and risk of renal cell cancer in a large population-based,
and from 900 frequency-matched control subjects. We used case-controlled study in Sweden.unconditional logistic regression to calculate odds ratios (ORs)
and 95% confidence intervals (CIs) as estimates of the relative
risks.
METHODSResults. An increased risk of renal cell cancer was observed
among men with a birth weight of $3500 g (adjusted OR 5 This was a population-based, case-controlled study of
1.3, 95% CI, 1.0 to 1.8) compared with men with a birth weight men and women aged 20 to 79 years, without previously
between 3000 and 3499 g, especially in the subgroup without
diagnosed renal cell cancer, who were born in the Nordichypertension or diabetes (adjusted OR 5 1.8, 95% CI, 1.2 to
countries and who resided in any of 19 counties in Swe-2.6). No clear association among men with a birth weight
,3000 g or among women was found. den between January 1, 1996, and June 30, 1998. We
Conclusions. Our study shows that conditions in utero, re- identified all incident cases of renal cell cancer in this
flected by birth weight, might affect the risk of renal cell cancer population through five of Sweden’s six regional cancer
in adulthood. It is unclear why no association was found among
registers. The patients were asked to participate in thewomen. Further studies, based on weight from birth certificates,
study through their physicians. A total of 1275 eligibleare needed to clarify this relationship.
case subjects was detected from whom 877 (69%) partici-
pated in the study. Nonparticipation was due to death
(12% of eligible cases), the patient being too ill or dis-The prenatal period has been suggested to be impor-
abled (6%), or the patient refusing participation (13%).tant for future cancer risk, and birth weight is often used
as a marker of fetal nutrition and growth in such studies. The cancer patients were contacted at least one month
High birth weight, indicating high levels of endogenous after diagnosis and on average after three months. All
pregnancy hormones, has been associated with breast, regional ethics committees and the Swedish Data Inspec-
prostate, and nonseminoma testicular cancer [1]. Low tion Board approved the study protocol.
birth weight has been related to an increased risk of Control subjects were randomly selected from the con-
hypertension [2, 3] and non–insulin-dependent diabetes tinuously updated nationwide Swedish population regis-
[3, 4], both associated with an increased risk of renal ter, frequency matched to the case patients by age (in
10-year strata) and sex. Of 2046 selected control subjects,
1508 (74%) agreed to participate in the study. Nonpartic-Key words: kidney neoplasms, neonates and cancer risk, prenatal can-
cer risk, kidney cancer. ipation was mainly due to refusing participation (24%
of selected control subjects).
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Table 1. Descriptive characteristics of renal cell cancer cases andpredefined categories: ,2500 g, 2500 to 2999 g, 3000 to
control subjects included in the analyses of birth weight
3499 g, 3500 to 3999 g, and $4000 g or “do not know.”
Men WomenBecause few persons reported a low (,2500 g) or high
Cases Controls Cases Controls($4000) birth weight, the two categories of the lowest
(N 5 378) (N 5 544) (N 5 270) (N 5 356)and the highest birth weight, respectively, were subse-
No (%) No (%) No (%) No (%)quently merged to increase statistical power. The ques-
tionnaire also covered information on education, ciga- Birth weight g
,2500 11 (3) 13 (2) 11 (4) 19 (5)rette smoking, usual adult weight, height, hypertension,
2500–2999 43 (11) 68 (13) 43 (16) 57 (16)and diabetes. 3000–3499 141 (37) 242 (44) 142 (53) 181 (51)
If needed, cases and control subjects were contacted 3500–3999 134 (35) 163 (30) 55 (20) 71 (19)
$4000 49 (13) 58 (11) 19 (7) 28 (8)by telephone to complete essential information missing
Age yearsin their responses. Among the controls, 284 failed to
20–39 11 (2) 9 (2) 7 (3) 6 (2)
return the mailed questionnaire and were instead inter- 40–49 34 (9) 36 (7) 23 (9) 31 (9)
50–59 92 (24) 119 (22) 63 (23) 81 (23)viewed only by telephone. This short telephone interview
60–69 128 (34) 196 (36) 83 (31) 124 (35)did not include the question on birth weight.
70–79 113 (30) 184 (34) 94 (35) 114 (32)
The association between categories of birth weight
Education years
and risk of renal cell cancer was measured using the ,10 220 (58) 302 (56) 159 (60) 203 (58)
10–12 83 (22) 114 (21) 65 (24) 75 (21)odds ratio (OR) and its 95% confidence intervals (CI),
.12 75 (20) 122 (23) 43 (16) 75 (21)computed from unconditional logistic regression models.
SmokingData were explored in models including only age (cate- Ever 237 (63) 335 (63) 130 (49) 137 (39)
gorized as ,40, 40 to 49, 50 to 59, 60 to 69, 70 to 79) as Never 140 (37) 195 (37) 137 (51) 213 (61)
Usual adult BMIawell as in models with age and the following covariates:
Q1 88 (24) 132 (25) 46 (18) 93 (28)education (,10, 10 to 12, .12 years), smoking (ever/
Q2 82 (22) 140 (27) 55 (21) 90 (26)
never), usual body mass index (BMI 5 kg/m2; divided Q3 74 (20) 132 (25) 64 (25) 83 (24)
Q4 130 (35) 123 (23) 93 (36) 74 (22)into quartiles based on the distributions among control
Heightbmen and women separately), height (divided into quartiles
Q1 61 (16) 86 (16) 56 (21) 82 (23)based on the distributions among control men and women Q2 75 (20) 150 (28) 45 (17) 70 (20)
separately), hypertension (ever/never), and diabetes Q3 94 (25) 130 (24) 90 (33) 99 (28)
Q4 148 (39) 177 (32) 78 (29) 104 (29)(ever/never).
Hypertension
Ever 144 (38) 129 (24) 100 (37) 81 (23)
Never 232 (62) 414 (76) 169 (63) 274 (77)RESULTS
Diabetes
A total of 648 cases of renal cell cancer and 900 control Yes 47 (13) 33 (6) 28 (11) 15 (4)
No 328 (87) 511 (94) 238 (89) 338 (69)subjects reported their birth weight and were included
aUsual adult BMI (kg/m2). Among men: Q1, ,22.72; Q2, 22.72–24.08; Q3,in analyses. The distributions according to birth weight,
24.09–25.34; Q4, $25.35. Among women: Q1, ,21.26; Q2, 21.26–22.85; Q3, 22.85–age, education, smoking, usual adult BMI, height, hyper- 24.61; Q4, $24.61.
bHeight (meters). Among men: Q1, ,1.72; Q2, 1.72–1.75; Q3, 1.76–1.79; Q4,tension, and diabetes among case and control subjects
$1.80. Among women: Q1, ,1.60; Q2, 1.60–1.62; Q3, 1.63–1.67; Q4, $1.68.are shown in Table 1.
Case subjects with missing or unknown birth weight
(N 5 229) tended to be older than case subjects who
reported their birth weight, while there was no difference among men with a birth weight of 3500 g and over com-
in sex distribution. After adjustment for age and sex, pared with those with a birth weight between 3000 and
they had lower education, were shorter, and suffered 3499 g (Table 2). Further adjustments for hypertension
more often from hypertension. No difference was seen in and diabetes did not affect the estimates markedly (data
the prevalence of smoking, BMI, or diabetes. Similarly, not shown). There was no clear association between a
control subjects with a missing or unknown birth weight birth weight below 3000 g and renal cell cancer risk
(N 5 608) were older than the control subjects who among men. We found no clear association between birth
reported their birth weight, but there were no differences weight and risk of renal cell cancer among women.
in sex distribution. After adjustments for age and sex, Low birth weight is associated with hypertension [2, 3]
they were less educated, smoked less, were shorter, and and non–insulin-dependent diabetes [3, 4], and both are
had a higher BMI. No difference was seen in the preva- associated with an increased risk of renal cell cancer
lence of hypertension or diabetes. [5–8]. Therefore, we investigated the association be-
In age-adjusted models as well as in multivariate mod- tween birth weight and renal cell cancer in a subset of
els further adjusting for education, smoking, normal the study population without hypertension or diabetes.
In this subsample, containing 380 case subjects (217 menadult BMI and height, an increased risk was observed
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Table 2. Odds ratio (OR) and 95% confidence interval (CI) of renal cell cancer in relation to categories of birth weight
Men Women
Model 1a Model 2b Model 1a Model 2b
N of N of
Birth weight g cases/controls OR 95% CI OR 95% CI cases/controls OR 95% CI OR 95% CI
All
,3000 54/81 1.1 0.8–1.7 1.2 0.8–1.8 54/76 0.9 0.6–1.4 1.0 0.6–1.5
3000–3499 141/242 1.0 Reference 1.0 Reference 142/181 1.0 Reference 1.0 Reference
$3500 183/221 1.4 1.0–1.9 1.3 1.0–1.8 74/99 1.0 0.7–1.4 0.9 0.6–1.3
Without hypertension or diabetes
,3000 32/57 1.5 0.9–2.5 1.6 0.9–2.8 40/50 1.3 0.8–2.1 1.3 0.8–2.3
3000–3499 68/174 1.0 Reference 1.0 Reference 83/132 1.0 Reference 1.0 Reference
$3500 117/163 1.8 1.3–2.7 1.8 1.2–2.6 40/81 0.8 0.5–1.2 0.8 0.5–1.3
aAdjusted for age
bAdjusted for age, education, smoking, usual adult BMI, and height
and 163 women) and 657 control subjects (394 men and mine whether this unlikely bias was introduced. Refusing
263 women), a birth weight of 3500 g or more was associ- to participate in the study was more common among the
ated with a significantly increased risk of renal cell cancer control subjects, but it is unlikely that this would be
among men but not among women (Table 2). Further- associated with birth weight. Another concern is that
more, we observed a nonsignificant increased risk of only 74% (648) of the cases and 60% (900) of the control
renal cell cancer among men with a birth weight below subjects answered the question on birth weight. This
3000 g. The association among women was less clear. difference in response is partly due to the fact that the
Because of the limited numbers, separate analyses on question on birth weight was not included in the short
men and women with hypertension or diabetes were not telephone interview with the 284 control subjects who
meaningful. failed to answer the mailed questionnaire. However, it
is unlikely that nonresponse might be associated with
birth weight. Therefore, selection bias probably has lim-DISCUSSION
ited influence on our findings.
In this population-based case-control study, which to Misclassification of birth weight might have affected
our knowledge is the first to investigate the relationship our results. Although birth weight was self-reported, val-
between birth weight and renal cell cancer, an increased
idation studies demonstrate that it is reported reliably
risk was observed among men with a high birth weight,
[11–13]. When self-reported birth weight was validatedwhile no clear association was found among men with a
in an American population-based, case-controlled studylow birth weight. Among women, neither high nor low
of breast cancer, the Spearman correlation coefficientbirth weight was clearly associated with risk of renal cell
between self-reported category of birth weight and birthcancer. In a subset of men and women without hyperten-
certificates was 0.83 for cases and 0.80 for controls [13].sion or diabetes, the association between high birth
This similarity in validity between cases and control sub-weight and risk of renal cell cancer among men persisted,
jects and the fact that birth weight is not a known riskand low birth weight was suggested to increase the risk
factor for renal cell cancer make differential misclassifi-among men. Also here, we found no clear association
cation an unlikely explanation of our findings. Nondiffer-between birth weight and renal cell cancer risk among
ential misclassification caused by incorrect recalling ofwomen.
birth weight only leads to an underestimation of the trueThe major strength of our study includes its popula-
association [14].tion-based design and the large number of cases. The
An association between high birth weight and renalSwedish regional cancer registers made it possible for
cell cancer is biologically plausible. Since birth weight isus to ascertain virtually all incident cases of renal cell
linearly correlated with the number of nephrons [10],cancer, and the National population registry made it
subjects with a high birth weight will have a larger num-possible to select population controls.
ber of nephrons and thereby more cells at risk of malig-One possible, but rather unlikely, limitation of our
nant transformation.study is selection bias. Although a substantial number
Also, an association between low birth weight andof the cancer patients (12%) died before they could be
renal cell cancer is biologically plausible. The total num-included or were too ill to participate (6%), this would
ber of nephrons, the structural and functional unit of theinfluence our results only if birth weight is associated
kidney, is defined at birth, after which no new nephronswith short-term prognosis of renal cell cancer. Since we
had no proxy interview information, we could not deter- are formed [15]. Fetal growth retardation, marked by
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